H A Remmer

Plain English
This research focused on a type of prostate cancer cell that is dormant and resistant to treatment, which often leads to cancer returning after a period of inactivity. The study found that these quiescent prostate cancer cells have a high level of a protein called HER2 on their surface, and using a specific drug that targets HER2 helped slow down tumor growth in mice. This discovery matters because targeting these dormant cells could lead to better treatments for patients by preventing cancer recurrence and making existing therapies more effective. Who this helps: This helps prostate cancer patients, especially those at high risk of recurrence.

Plain English
This study looked at how aging affects proteins in the aorta, the main artery in the body, both in healthy individuals and those with a condition called thoracic aortic aneurysm (TAA). Researchers compared the aorta from 17 healthy people and 20 people who had surgery for TAA, finding that older aortas show more changes linked to energy metabolism, while younger aortas are more involved in immune responses. Specifically, they discovered that as people age, certain proteins related to aortic health change, indicating that treatments for conditions like TAA may need to be tailored based on a person's age. Who this helps: This assists doctors and researchers focusing on vascular diseases, particularly in developing age-specific treatments for patients with aortic conditions.

Plain English
Researchers studied how obesity affects the endometrium, the tissue lining the uterus, by comparing women with obesity to women of normal weight. They found that women with obesity had a higher average of 2,437 proteins in their endometrial tissue samples, while normal-weight women averaged around 2,059 proteins. This imbalance, especially with the underrepresentation of important proteins like the progesterone receptor, could lead to problems like abnormal menstrual bleeding and affect reproductive health. Who this helps: This information is valuable for doctors and healthcare providers working with patients who are obese and may face reproductive health issues.

Plain English
This study examined a specific type of antibody related to myeloma (a type of blood cancer) and found that researchers were accidentally using a wrong version of the antibody. They discovered that a nearly identical version of the antibody, which they originally thought was incorrect, actually worked well in targeting human CD63, an important protein. This discovery is significant because it helps improve how scientists create effective antibodies for treating diseases. Who this helps: This helps patients who may benefit from better-targeted antibody treatments.

Plain English
In pigs with isolated traumatic brain injury, a single dose of valproic acid given one hour after injury reduced brain lesion size by 50% and lowered blood levels of a brain injury marker. Mass spectrometry imaging showed the drug concentrated in injured blood vessel walls and readily penetrated damaged brain tissue. Pathway analysis of over 500 proteins revealed the drug activates calcium signaling and cell survival machinery in the brain.

Plain English
Researchers found that a protein called ID-1 becomes modified in rheumatoid arthritis patients' joints in a way that triggers the immune system to attack it—this modification doesn't happen in healthy people. When they removed ID-1 from arthritis cells in the lab, the cells produced more inflammatory chemicals and grew less, suggesting ID-1 normally helps control inflammation in the joint. ID-1 levels in patients' blood dropped after they received anti-inflammatory treatment, and three specific spots on the protein are responsible for triggering the immune attack. **Why it matters:** This discovery identifies a new target that the immune system mistakenly attacks in rheumatoid arthritis, which could help explain why the disease develops and might lead to better treatments or diagnostic tests.

Plain English
This study looked at how mRNA and protein levels change in the skin of people with psoriasis, a condition that causes red, scaly patches. Researchers found over 4,100 genes and nearly 750 proteins that were expressed differently in the affected skin compared to normal skin. Notably, there were many more proteins increased than decreased, showing a significant rise in certain proteins that help in cell processes, while their mRNA levels did not change as expected. These findings are important because they reveal that focusing on proteins instead of just mRNA can provide new insights into how psoriasis works and could lead to better treatments. Who this helps: This benefits patients with psoriasis by informing more effective therapies and management strategies.

Plain English
This study explored how sunlight affects a protein called decorin in human skin. Researchers found that exposure to UV light caused significant degradation of decorin, which is important for protecting collagen, a key structural protein in the skin. Specifically, they noted that neutrophil elastase, an enzyme released by certain immune cells, plays a major role in breaking down decorin, which can lead to more damage to collagen and contribute to skin aging. Who this helps: This helps patients concerned about skin aging and doctors seeking ways to protect skin health from sun damage.

Plain English
Researchers studied how to better create a specific type of membrane protein, called phospholamban, by using a technique called electron paramagnetic resonance (EPR). They found that by adding a special label (TOAC) to this protein during its synthesis, they could clearly see how the protein changed and moved at each step of the process, allowing them to confirm that the synthesis was done correctly. This is important because having accurate methods to create proteins like phospholamban can aid in studying heart function and potentially lead to new treatments for heart disease. Who this helps: This helps researchers and scientists working on heart health and related therapies.

Plain English
This study focused on creating new types of peptide complexes that can bind to heme, an important molecule in our bodies. Researchers found that these new cyclic and hairpin peptides can attach to heme about 5 million times more effectively than a common binding substance, histidine. This matters because stronger binding can lead to better understanding and potential applications in drug development and disease treatment. Who this helps: This benefits researchers and pharmaceutical companies working on treatments related to blood and oxygen transport.

Plain English
This study examined a side reaction that happens during the process of making peptides, specifically when removing protective groups from arginine. Researchers found that when certain protective groups were removed, two unexpected byproducts, O-sulfo-serine and O-sulfo-threonine, were produced in large amounts. This finding matters because it highlights a potential issue in peptide synthesis that could affect the quality and effectiveness of the peptides produced for research or medical use. Who this helps: This research benefits scientists and manufacturers involved in peptide development.